Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 122 for “"Osteolytic"”.

  1. TSP-1 in Osteoclastogenesis and Osteolytic Bone Metastasis

    … osteoclasts - leading to the development of osteolytic or osteoblastic metastasis characterized respectively by excessive bone degradation or deposition. Osteolytic lesions are the most common type of breast cancer bone metastasis. The matricellular protein thrombospondin-1 (TSP-1) plays a …

    the-open-u Download PDF for TSP-1 in Osteoclastogenesis and Osteolytic Bone Metastasis (opens in a new tab)

  2. CD166 modulates disease progression and osteolytic disease in multiple myeloma

    … cells in the bone marrow (BM) and by multiple osteolytic lesions throughout the skeleton. We previously reported that CD166 is a functional molecule on normal hematopoietic stem cells (HSC) that plays a critical role in HSC homing and engraftment, suggesting that CD166 is involved in HSC …

    iupui Repository record for CD166 modulates disease progression and osteolytic disease in multiple myeloma (opens in a new tab)

  3. A STUDY ON STRUCTURAL, VISCOELASTIC PROPERTY AND OSTEOBLAST CHANGES IN OSTEOLYTIC METASTASES

    Osteolytic bone metastasis shows enhanced bone resorption and impaired bone formation. Sclerotic (tissue hardening) development is common but little is known about intrinsic mechanical property changes. The effect of tumour on bone cell mechanosensing and thus bone formation is also unknown. In …

    nus Repository record for A STUDY ON STRUCTURAL, VISCOELASTIC PROPERTY AND OSTEOBLAST CHANGES IN OSTEOLYTIC METASTASES (opens in a new tab) Download file for A STUDY ON STRUCTURAL, VISCOELASTIC PROPERTY AND OSTEOBLAST CHANGES IN OSTEOLYTIC METASTASES (opens in a new tab)

  4. Strategies to Augment Mesenchymal Stem Cell Mediated Bone Regeneration in Fracture, Fusion, and Osteolytic Lesions

    … (OCM) to mimic the osteogenic environment. Osteolytic MBD is characterized by resorption of bone as the tumor progresses. The interplay between osteolytic bone tumors and osteoprogenitors was mimicked by co-culturing hMSCs with murine osteosarcoma (MOSJ) cells on OCM coated polystyrene beads …

    tamu Repository record for Strategies to Augment Mesenchymal Stem Cell Mediated Bone Regeneration in Fracture, Fusion, and Osteolytic Lesions (opens in a new tab)

  5. Progression of Breast Cancer Metastatic Disease and Subsequent Osteolytic Bone Degradation Mediated by Oncostatin M

    Breast cancer is the most diagnosed cancer in women and is the second most common cancer-related death for women worldwide. While the primary tumor itself is not lethal, the metastases that disrupt vital organ functions pose a significant clinical challenge. Seventy percent of women with metastatic …

    boise Repository record for Progression of Breast Cancer Metastatic Disease and Subsequent Osteolytic Bone Degradation Mediated by Oncostatin M (opens in a new tab)

  6. Adoptive transfer of ex vivo expanded gamma delta T cells targeting osteolytic cancer in the bone

    … based adoptive transfer using animal models of osteolytic breast cancer and osteosarcoma. Cytotoxic Vγ9Vδ2 T cells were expanded ex vivo from peripheral blood using IL-2 and zoledronic acid (ZOL). In vitro, expanded Vγ9Vδ2 T cells were cytotoxic against a panel of breast cancer and osteosarcoma …

    adelaide Repository record for Adoptive transfer of ex vivo expanded gamma delta T cells targeting osteolytic cancer in the bone (opens in a new tab)

  7. Targeting the PI3K and Ras Signal Transduction Pathways in a Murine Model of Osteolytic Breast Cancer Metastasis

    … of MDA-MB-231-EGFP/Luc2 human breast cancer osteolytic metastases. PI3K inhibition did not directly affect bone-colonized cancer cells, however, it demonstrated an attenuation of bone loss, whereas MEK inhibition resulted in a significant reduction of both tumor growth and osteolysis. …

    calgary Repository record for Targeting the PI3K and Ras Signal Transduction Pathways in a Murine Model of Osteolytic Breast Cancer Metastasis (opens in a new tab)

  8. Using the MDA-MB-231/EGFP-Luc2 breast cancer model to explore novel treatments for osteolytic metastases.

    The ability to recruit and expand new blood vessels is an essential component of tumour growth. Hence, the main goal of this study was to determine whether we could prevent the growth of bone metastases by blocking angiogenesis via the use of the vascular disrupting agent (VDA), DMXAA, either …

    calgary Repository record for Using the MDA-MB-231/EGFP-Luc2 breast cancer model to explore novel treatments for osteolytic metastases. (opens in a new tab)

  9. 3D visualization and characterization of the early bone metastatic niche: from cancer cell homing to small osteolytic lesions

    … and progression of breast cancer induced osteolytic lesions. Hence, we aim to develop an experimental mouse model of breast cancer bone metastasis to detect and characterize early osteolytic lesions in 3D. In order to study the dynamic bone (re)modeling behavior in a pathological model, a …

    fu-berlin Repository record for 3D visualization and characterization of the early bone metastatic niche: from cancer cell homing to small osteolytic lesions (opens in a new tab)

  10. The Roles of Estrogen and Transforming Growth Factor-β Signaling Pathways in Estrogen Receptor-Positive Breast Cancer Osteolytic Bone Metastasis Progression

    … (BMETs). These incurable and primarily osteolytic ERa-positive (ER+) BMETs often recur decades after cessation of hormone therapy and/or in conjunction with ligand-independent ER mutations. In addition, despite similar rates of both ER- and ER+ tumors disseminating to the bone, ER+ …

    arizona-thes Repository record for The Roles of Estrogen and Transforming Growth Factor-β Signaling Pathways in Estrogen Receptor-Positive Breast Cancer Osteolytic Bone Metastasis Progression (opens in a new tab)

  11. A Therapeutic Strategy Targeting the Dickkopf Wnt Signaling Pathway Inhibitor 1 (Dkk-1) in Osteolytic Osteosarcoma Results in Tumor Suppression and Bone Protection

    … bone repair, exacerbating the formation of osteolytic lesions caused by tumor infiltration. Therefore, targeting the expression of Dkk-1 in OS could reduce tumor burden and increase susceptibility to chemotherapeutics while restoring bone repair. Herein, we report that inhibiting Dkk-1 …

    tamu Repository record for A Therapeutic Strategy Targeting the Dickkopf Wnt Signaling Pathway Inhibitor 1 (Dkk-1) in Osteolytic Osteosarcoma Results in Tumor Suppression and Bone Protection (opens in a new tab)

  12. Adaptive response of the bone after mechanical stimulation in the murine MOPC315.BM myeloma model

    ABSTRACT Osteolytic bone disease (BD) is a hallmark of multiple myeloma (MM), affecting 80% of patients with MM. Osteolytic bone disease develops when tumor cells infiltrate the bone marrow and shift the balance of the bone remodeling process towards massive bone resorption. This results in …

    wurz-thes Repository record for Adaptive response of the bone after mechanical stimulation in the murine MOPC315.BM myeloma model (opens in a new tab)

  13. Automated Quantitative Analysis of Bone Stability and Tumour Burden in the Metastatic Rat Spine

    … the metastatic spine have focused primarily on osteolytic tumours. Local and systemic treatments have impacted the nature of vertebral metastasis, increasing the occurrence of mixed osteolytic and osteoblastic disease. Thus, it is important to focus analyses on models able to accurately …

    toronto-retro Repository record for Automated Quantitative Analysis of Bone Stability and Tumour Burden in the Metastatic Rat Spine (opens in a new tab)

  14. Bone-Specific Metabolism and Mechanism of Action of Curcuminoids in Blocking Osteolysis in Breast Cancer and Other Resorptive Bone Diseases

    … age-related bone loss, rheumatoid arthritis, and osteolytic bone metastases, affect over 55 million Americans each year. Breast cancer bone metastases, the model of bone resorptive disorders to be used here, causes osteolysis through a “vicious cycle”, whereby osteoclasts release growth factors …

    arizona-thes Repository record for Bone-Specific Metabolism and Mechanism of Action of Curcuminoids in Blocking Osteolysis in Breast Cancer and Other Resorptive Bone Diseases (opens in a new tab)

  15. Breast Tumor Stiffness and Bone Metastasis: How “Soil Selects Soil”

    … disease. Although predictive gene signatures of osteolytic metastasis have been identified, their genesis remains obscure. Current models propose that bone metastases originate from rare subclones that arise stochastically during clonal evolution of primary tumors. In contrast, we reveal a …

    arizona-thes Repository record for Breast Tumor Stiffness and Bone Metastasis: How “Soil Selects Soil” (opens in a new tab)

  16. Wnt-Targeted Therapy to Treat Myeloma-Induced Bone Loss and Prevent Disease Relapse

    … bone marrow, systemic bone loss and destructive osteolytic bone lesions. These are mediated by an imbalance in bone remodelling, in which bone resorption is exacerbated and bone formation is suppressed. More than 90% of MM patients present with osteolytic lesions that can lead to pain and …

    unsw Repository record for Wnt-Targeted Therapy to Treat Myeloma-Induced Bone Loss and Prevent Disease Relapse (opens in a new tab)

  17. Targeting bone-microenvironment-tumour cell interactions : IGF-1 receptor kinase inhibitors.

    … a novel therapeutic agent for the treatment of osteolytic bone disease. Co-culture or conditioned medium studies using human or mouse cancer cell lines were used to develop an in vitro model system of tumour cell – bone cell interactions. This showed that osteolytic tumour cells enhance …

    edinburgh Repository record for Targeting bone-microenvironment-tumour cell interactions : IGF-1 receptor kinase inhibitors. (opens in a new tab)

  18. Investigating the biomechanics and genetics of acetabular peri-prosthetic osteolysis

    Osteolytic lesions in the acetabulum of the pelvis, as a long-term consequence of total hip arthroplasty (THA), can lead to implant loosening and failure. These lesions are primarily considered to be a result of peri-prosthetic cells responding to wear debris generated mechanically from the …

    adelaide Repository record for Investigating the biomechanics and genetics of acetabular peri-prosthetic osteolysis (opens in a new tab)

  19. Investigating the effects of CSF-1R and PI3Kdelta inhibition on a breast cancer bone metastasis model

    … that GW2580 and ABT-869 significantly decreased osteolytic lesions and tumor growth in MDA-MB-231 bone metastases. Also, GW2580 increased bone mass in normal C57BL/6 mice, validating the effect of this inhibitor on CSF-1R-expressing osteoclasts in vivo. Since IC87114 failed to reduce tumor growth …

    calgary Repository record for Investigating the effects of CSF-1R and PI3Kdelta inhibition on a breast cancer bone metastasis model (opens in a new tab)

  20. Quantification of Changes in Vertebral Bone Quality in the Presence of Metastases

    … (osteoblastic), excess bone-resorption (osteolytic) or a mixture of the two. Previous work has assessed the impact of metastatic involvement on bone microarchitecture and mineral content, establishing relationships between these characteristics and mechanical behaviour. However, less well …

    toronto-retro Repository record for Quantification of Changes in Vertebral Bone Quality in the Presence of Metastases (opens in a new tab)

Page 1 of 7